Thomas Hoerger, PhD, talks about minimizing costs while achieving better diabetes care.
Thomas Hoerger, PhD, talks about minimizing costs and obtaining better diabetes treatment outcomes. In order to lower costs in patients with diabetes, hospital admissions must be controlled through achieving and maintaining glycemic, blood pressure, and cholesterol level targets.
When asked if costs associated with diabetes management could be reigned in, Dr. Hoerger states that diabetes prevention is an integral key to controlling costs. It’s important to monitor people without diabetes in order to slow the growth of the disease.
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen